[HTML][HTML] Metabolic drivers of non-alcoholic fatty liver disease
KK Bence, MJ Birnbaum - Molecular metabolism, 2021 - Elsevier
Background The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing
worldwide parallel to the global obesity epidemic. NAFLD encompasses a range of liver …
worldwide parallel to the global obesity epidemic. NAFLD encompasses a range of liver …
Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine
N Perez-Diaz-del-Campo… - Current Opinion in …, 2022 - journals.lww.com
The growing NAFLD pandemic urges clinicians to seek alternatives for screening, early
diagnosis, and follow-up, especially for those with contraindications for liver biopsy. New …
diagnosis, and follow-up, especially for those with contraindications for liver biopsy. New …
Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population
J Cai, C Lin, S Lai, Y Liu, M Liang, Y Qin… - Lipids in health and …, 2021 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) has been entitled as metabolic-
dysfunction associated fatty liver disease (MAFLD). Therefore anthropometric indicators of …
dysfunction associated fatty liver disease (MAFLD). Therefore anthropometric indicators of …
Mediators of dietary diversity score (DDS) on NAFLD in Iranian adults: a structural equation modeling study
A Doustmohammadian, B Amirkalali… - European Journal of …, 2023 - nature.com
Background The current study examines the association between the Dietary Diversity
Score (DDS) and nonalcoholic fatty liver disease (NAFLD) in Iranian adults using structural …
Score (DDS) and nonalcoholic fatty liver disease (NAFLD) in Iranian adults using structural …
Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross …
A Aydin, S Goktas Aydin - Current Medical Research and Opinion, 2024 - Taylor & Francis
Objective Non-alcoholic fatty liver disease (NAFLD is a spectrum of liver disease with a
rising prevalence, ranging from simple steatosis to steatohepatitis and cirrhosis, where a …
rising prevalence, ranging from simple steatosis to steatohepatitis and cirrhosis, where a …
A Body shape index significantly predicts MRI-defined abdominal adipose tissue depots in non-obese Asian Indians with type 2 diabetes mellitus
S Anoop, J Krakauer, N Krakauer… - BMJ Open Diabetes …, 2020 - drc.bmj.com
Introduction We aimed to determine the correlations of volumes of subcutaneous abdominal
adipose tissue (SCAT)(anterior, posterior, superficial and deep), total SCAT, intraperitoneal …
adipose tissue (SCAT)(anterior, posterior, superficial and deep), total SCAT, intraperitoneal …
Validity of fatty liver disease indices in the presence of alcohol consumption
O Danielsson, J Nano, K Pahkala… - Scandinavian Journal …, 2022 - Taylor & Francis
Background & aims Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver
disease frequently coexist. While several blood-based indices exist for the detection of …
disease frequently coexist. While several blood-based indices exist for the detection of …
Chinese visceral adipose index shows superior diagnostic performance in predicting the risk of metabolic dysfunction associated fatty liver disease in early …
Y Lu, L Ge, H Yang, Y He, Y Wang - Diabetes, Metabolic Syndrome …, 2023 - Taylor & Francis
Background Previous studies have reported the diagnostic values of multiple obesity
indicators for predicting the risk of non-alcoholic fatty liver disease. However, the diagnostic …
indicators for predicting the risk of non-alcoholic fatty liver disease. However, the diagnostic …
[HTML][HTML] Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?
J Trinks, MF Mascardi, A Gadano… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Unmet needs exist in metabolic dysfunction-associated steatotic liver disease (MASLD) risk
stratification. Our ability to identify patients with MASLD with advanced fibrosis and at higher …
stratification. Our ability to identify patients with MASLD with advanced fibrosis and at higher …
人体肥胖测量指标与非酒精性脂肪性肝病的相关性.
童聪， 李亚年， 顾达， 赵祥安… - Journal of Clinical …, 2021 - search.ebscohost.com
童聪1 ,李亚年2 ,顾达1 ,赵祥安3 ,向晓星 Page 1 + 人体肥胖测量指标与非酒精性脂肪性肝病的
相关性 童聪1 ,李亚年2 ,顾达1 ,赵祥安3 ,向晓星3 1 扬州大学医学院,江苏扬州225009;2 大连 …
相关性 童聪1 ,李亚年2 ,顾达1 ,赵祥安3 ,向晓星3 1 扬州大学医学院,江苏扬州225009;2 大连 …